GlaxoSmithKline Pharmaceuticals Limited (BOM:500660)

Market Cap	471.53B
Revenue (ttm)	37.40B
Net Income (ttm)	9.50B
Shares Out	169.41M
EPS (ttm)	56.10
PE Ratio	49.62
Forward PE	44.58
Dividend	42.00 (1.53%)
Ex-Dividend Date	May 30, 2025

Volume	1,738
Average Volume	5,157
Open	2,748.15
Previous Close	2,748.15
Day's Range	2,748.15 - 2,813.35
52-Week Range	1,924.30 - 3,515.95
Beta	0.06
RSI	38.08
Earnings Date	Aug 1, 2025

About BOM:500660

GlaxoSmithKline Pharmaceuticals Limited manufactures, distributes, and trades in pharmaceuticals in India and internationally. The company offers vaccines, such as Infanrix Hexa for vaccination of infants against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and disease caused by Haemophilus influenzae type B; Synflorix for active immunization of infants against pneumococcal diseases and acute otitis media; Havrix for active immunization against disease caused by Hepatitis A virus; Menveo to prevent invasive meningococcal disease;...

• Industry: Pharmaceutical Preparations
• Founded: 1924
• Employees: 3,113
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 500660

Financial Performance

In 2024, BOM:500660's revenue was 37.49 billion, an increase of 8.56% compared to the previous year's 34.54 billion. Earnings were 9.28 billion, an increase of 57.23%.